Literature DB >> 3562814

Abdominal lymphadenopathy in benign diseases: CT detection.

S J Deutch, M A Sandler, M B Alpern.   

Abstract

A review of 2,100 consecutive computed tomographic (CT) examinations yielded 160 cases of abdominal lymphadenopathy, of which nine (6%) were secondary to benign diseases. Contrary to previous reports, size, location, contour, density, relationship to the aorta, and presence of mass effect were not helpful in distinguishing benign from malignant lymphadenopathy. In some cases, ancillary CT findings, conventional radiographs, and clinical setting may suggest a specific benign entity. Benign processes should be considered in the differential diagnosis of abdominal lymphadenopathy in the appropriate clinical setting, particularly if the patient does not have a known carcinoma.

Entities:  

Mesh:

Year:  1987        PMID: 3562814     DOI: 10.1148/radiology.163.2.3562814

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Retroperitoneal lymphadenopathy: an extrahepatic feature of chronic active hepatitis.

Authors:  T Hayek; A Markel; M Goldfeld; Y Ben-Arie; G J Brook
Journal:  Postgrad Med J       Date:  1994-05       Impact factor: 2.401

2.  Perihepatic nodes detected by point-of-care ultrasound in acute hepatitis and acute-on-chronic liver disease.

Authors:  I Che Feng; Szu Jen Wang; Ming Jen Sheu; Lok-Beng Koay; Ching Yih Lin; Chung Han Ho; Chi Shu Sun; Hsing Tao Kuo
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

3.  Support vector machine model for diagnosis of lymph node metastasis in gastric cancer with multidetector computed tomography: a preliminary study.

Authors:  Xiao-Peng Zhang; Zhi-Long Wang; Lei Tang; Ying-Shi Sun; Kun Cao; Yun Gao
Journal:  BMC Cancer       Date:  2011-01-11       Impact factor: 4.430

4.  An evidential reasoning based model for diagnosis of lymph node metastasis in gastric cancer.

Authors:  Zhi-Guo Zhou; Fang Liu; Li-Cheng Jiao; Zhi-Long Wang; Xiao-Peng Zhang; Xiao-Dong Wang; Xiao-Zhuo Luo
Journal:  BMC Med Inform Decis Mak       Date:  2013-11-06       Impact factor: 2.796

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.